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1-Introduction
Breast cancer is a complex and multifactorial disease resulting from abnormal growth of cells begins in the lining layer of duct or lobe of the breast. that leads to malignant tumor formation . It is the commonest malignancy in women, affecting women during their lifetime .Bc, considered the most common cancer, is now leveled as the first among all cancers diagnosed in women (Kolahdoozan, etal, 2010; Ferlay et al., 2015 ) .(IL-6)is a cytokines and consider as pleiotropic inflammatory cytokines produced by neutrophil and from macrophages, monocytes, T-cells, B-cells and fibroblasts, endothelial cells, osteoblasts and tumor cells (Salgado,etal,2003 Kishimoto 2006 Fields , 2009 ; Guillermo, and Descoteaux,2014)) ). IL-6 plays a chief role in pathogenesis and progress of malignancies. It helps tumor to grow through inhibiting apoptosis of cancer cells and the stimulation of tumor angiogenesis, ( Salgado, et al.,2003) ,also IL-6 contributes to the proliferation of many cancer cells and, especially those at the advanced stage of development, IL-6 concentrations can depend on the clinical tumor stage and histological tumor grade (Brozek ,etal.,2005 Bellone,etal.,2005) .However IL-6 overexpression was found in breast carcinoma and in prostate cancer (Garcia,etal.,2005; Culig,etal.,2005) . The ovarian steroid hormones progesterone and estrogen play critical roles in the development and progression of breast cancer and endometriosis (Shao et al., 2014) .Estrogen receptor and progesterone receptor, along with human epidermal growth factor receptor 2 (HER2), are used to classify phenotypes in breast cancers and to predict response to specific therapies (Cadoo et al .,2013) .Bc is a heterogeneous disease, and its prognosis may depend on characteristics of tumor (Onitilo,etal.,2009 ).Therefore, the roles of IL-6 related markers in mediation of tumor growth and metastasis could be influenced by distinct subtypes that have been identified on the basis of gene or protein expression in tumor tissue (Seruga ,etal.,2008) ,different breast cancer subtypes may produce distinct inflammatory mediators, which may affect their distinct tumor progression pathways (Gonzalez,etal.,2011; Levano,etal.,2011),so this study have focused on the use of IL-6 as a prognostic factor for breast cancer.
Material and mothed

Sample collection
In this study total number of (130)cases was analyzed and (60) cases were subjected to Histopathological and Immunohistochemcal studies. The recent study evaluated level of (IL-6) in all (BC) patients and (16)control ,the data showed highly significant difference and the mean level was increased in (71)case compared to control Immunological studies: In this study we measured IL-6 level in the serum of the breast cancer patients by using EnzymeLinked Immuno Sorbent Assay (ELISA) , human (IL-6) ELISA kit.
Histopathological studies: the histopathological study of tumor stage was assessed according to the criteria established by the seventh edition of the American Joint Committee on Cancer (AJCC) staging manual as SI, SII and SIII , while the tumor grade was determined according to the Scarff-BloomRichardson classification modified by Elston and Ellis also as GI,GII and GIII.
Immunohistochemstiry: Hormone receptors(ER,PR and HER-2) were assessed via immunohistochemistery mothed (IHC) .
Statistical analysis:
The data of this study were analytic with one way anova ,t-test and chi-square by using Spss program version 22.
Results:
1-Clinical staging and histologic grading
Dependent on Tumor-node-metastasis (TNM) system was used to classified the stage of BC, in our patients out of (130) cases , staging system can be applied only to (60) cases , this study had reported (1) There are (40) patients were positive for ER,(66.7%) distributed according scoring system, while only (20) of patients were negative for this receptor(33.3%), the difference between the two percentages was significant (P > 0.05), Table( 3) Figure(1 ). While (45)cases were positive for PR (75%) and (15) cases were (25%) significant (P > 0.05), Table ( 
Figure 1. Breast Invasive Duct Carcinoma, LuminalA Subtype Showing Positive Nuclear Immunostainingfor ER (A) Negative (B), 1+ (C)2+(D)3+(E)4+(F)5+(G)6+ Magnification x400
3-HER-2
Result found (33)cases were positive (55%),and(27) cases were negative (45%) of patients, the percentage of cases of breast tumor were significant (P > 0.05) Table (5) Figure( 3) 
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Figure 3. Breast Invasive Ductal Carcinoma, LuminalA Subtype Showing Positive Nuclear Immunostaining for HER2 (A) Negative (B), 1+ (C)2+(D)3+(E)4+ Magnification x400
3-Evaluation of 6 (IL-6) levels
The data showed elevated level of IL-6 in (BC) patient reached to (41.2732 pg/ml), as compared to control that the level of (IL-6)was (.2254pg/ml), with significant difference (p ˃0.05) Table (6). 
4-Correlation between (IL-6) level and staging and grading
Also the study determined the relationship between tumor staging and level of (IL-6) mean levels The results showed highest level was in patients at stage3(S3) that the (IL-6) level reached to (76.5465pg/ml), while the patients from S2 the (IL-6)level was (13.9293pg/ml), and reached to (8.3400 pg/ml) in patient from (S1), statistically no significant difference observed between (S1,S2)and no significant difference also between (S1 , S3) when (IL-6) level compared ,but high significant difference was recorded between (S2,S3)at (P=0.000), Table(7). Also the results showed high significant increased with(IL-6) levels in G3 patients that the mean level was (57.1746pg/ml) , (19. 9030 pg/ml) and(19.9030 pg/ml) in patient whose diagnosed with(G2,G1) , respectively, also no significant difference between (G1,G2) and(G1,G3) but high significant difference recorded between (G2,G3)at (p=0.010) (Table8). 
5-Correlation between (IL-6) level and (ER,PR,HER2) receptor expression
Data and figures from this study indicated to the relationship between ( IL-6) level and expression of each receptor in (BC) patients ,the result showed increased with( IL-6) level reached (56.3145 pg/ml± 11.14360pg/ml) with( ER+)comparative with( ER-) which the (IL-6)level was (19.1690±6.53831 pg/ml) at high significant differences( p=.000 ), Table( 4) and increased in PR+(62.5028 pg/ml) as compared with PR-(11.6953 pg/ml) also with high significant differences( p=.000 ), Table( 5) while the result showed increased mean level of (IL-6) with Her2-(62.6413 pg/ml) as compared with Her2+(27.8280 pg/ml) (Salgado etal,2003; victor etal,2015) .
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IL-6 levels correlation with clinical stage and histologic grade
Present study proved the relationship between mean level of (IL-6)in serum of all (BC) patients that diagnosed with S(III),then S(II) and the lowest level was measured in patients with (SI), this results may be related to late stage of tumor growth and all patients(mastectomy)so this factor correlate with clinical stage and this in agreement with other researchers who showed that there was detectable correlation between stage and the levels of (IL-6),and high level was frequently in S( III) than in S(I and II),it produced by tumor cells and it has able to promote tumor growth by up-regulating anti apoptotic and angiogenic proteins in tumor cells Ordemann etal., Further, IL-6 is associated with angiogenesis by optimize of its ability to induce the mRNA of vascular endothelial growth factor (VEGF), which is typically adirect angiogen Chavey C,etal.,(2007) Also another study showed the displayed role of(IL-6)that induced the expression of vascular endothelial growth factor and referred to over expression of (IL-6) in human basal cell carcinoma lines increases antiapoptotic activity and tumorigenic potency(Cohen T.,etal.,(1996) Jee SH, etal., (2001) .Relationship between IL-6 with vascular endothelial growth factor in cervical cancer the, these findingss point to an important role of IL-6 in the progression of breast cancer at least in patients with advanced disease(Wei LH,etal.,2001).
Level of IL-6 relation to hormone receptors (ER,PR and HER2)
In the current study we investigated the relationship of (IL-6) hormone receptors in (BC) samples ,we observed an association of levels of IL-6 with ER,PR the result showed increased mean level of ( IL-6) with positive (ER+)as compared with negative (ER-) with high significant differences at( p=.000 ),and increased in (PR+) receptors as compared with (PR-) also with high significant differences( p=.000 ),these results may be regarded that the (IL-6) associated with (ER)(PR) and (HER2) receptors which it was mammary markers, and this results agreed with ( Fontanini G.,etal.,1999) who observed ,level of IL-6 was expression directly associated with the expression of ER , PR that symbolize important mammary differentiation markers, ERpositive tumors were also reactive with IL-6 (P =.02), and the percentage of ER-positive cells was directly related to that of IL-6-positive cells (P.00005),same the results were obtained with regard to the percentages of PR-positive cells (P =025). The possible contact between interleukins and steroid hormones has been suggested by (Reed ,et al,1992) and estradiol dehydrogenase activities in (BC) cells,( ER-) positive human breast cancer cells express the IL-6 receptor and their proliferation was inhibited by addition of IL-6, Chen et al, (1988) and Chiu et al,(1996) , Also study by (Young A.,etal.,2013)whose observed an association on (IL-6 and IL-8) level with (BC) recurrence; these associations differed according to tumor subtype. other studies have established that cytokines can enhance, inhibit, or have no effect on cell proliferation and differentiation depending on the cell type examined, implying that the role of cytokines in mediation of tumor growth could be affected by tumor subtype every tumor subtype, may correspond differently with the immune system and produce a distinct cytokine profile these findings estimate that IL-6 may stimulate tumor cell motility and invasion for . This result may be clarified the role of (IL-6) with cell growth, proliferation ,differentiation and the over expression of(HER2) interact with immune system and lead to induced tumor growth , this result agreed with the studies showed increased with (IL-6) level in relation to patients with (HER2-) negative receptor (Young Ae.,etal.,2013; Sherif A.,etal.,2016). Moreover, the recent study found that the levels of IL-6 in breast recurrence may differ according to HER2 status ,as well as levels of IL-6 showed a positive association with breast cancer recurrence only among patients with (HER2-) tumors with high mean as compared to patients with HER2+ ,our results deal with study made by Salhia B.,etal.,(2011) whose observed high level of IL-6 associated with HER2-in patients of BC ,other study done by Young Ae.,etal., (2013) showed that increased level of IL-6 in HER2-with BC patients ,similarly ,our results agree with Egyptian study done by Sherif A.,etal.,(2016) ,they observed level of IL-6 may increased and correlate with HER2-,As known HER2 is a transmembrane tyrosine kinase receptor that mediates growth, differentiation, and survival of cells; overexpression of HER2 at the cell membrane may lead to activation of multiple signaling complexes 
